ITMI922885A0 - Composizioni farmaceutiche a rilascio controllato contenenti nicergolina - Google Patents

Composizioni farmaceutiche a rilascio controllato contenenti nicergolina

Info

Publication number
ITMI922885A0
ITMI922885A0 IT92MI2885A ITMI922885A ITMI922885A0 IT MI922885 A0 ITMI922885 A0 IT MI922885A0 IT 92MI2885 A IT92MI2885 A IT 92MI2885A IT MI922885 A ITMI922885 A IT MI922885A IT MI922885 A0 ITMI922885 A0 IT MI922885A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
controlled release
compositions containing
release pharmaceutical
nicergoline
Prior art date
Application number
IT92MI2885A
Other languages
English (en)
Inventor
Giorgio Pifferi
Roberto Seghizzi
Romano Vitali
Luigi Zini
Original Assignee
Ida Holding S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ida Holding S P A filed Critical Ida Holding S P A
Publication of ITMI922885A0 publication Critical patent/ITMI922885A0/it
Priority to ITMI922885A priority Critical patent/IT1256743B/it
Priority to EP93120199A priority patent/EP0602619A1/en
Priority to JP5343465A priority patent/JPH0748256A/ja
Priority to CZ932775A priority patent/CZ277593A3/cs
Priority to PL93301513A priority patent/PL301513A1/xx
Priority to CN93112890A priority patent/CN1093254A/zh
Priority to HU9303633A priority patent/HUT66371A/hu
Priority to KR1019930028487A priority patent/KR950016748A/ko
Publication of ITMI922885A1 publication Critical patent/ITMI922885A1/it
Application granted granted Critical
Publication of IT1256743B publication Critical patent/IT1256743B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI922885A 1992-12-18 1992-12-18 Composizioni farmaceutiche a rilascio controllato contenenti nicergolina IT1256743B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITMI922885A IT1256743B (it) 1992-12-18 1992-12-18 Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
EP93120199A EP0602619A1 (en) 1992-12-18 1993-12-15 Controlled-release pharmaceutical compositions containing nicergoline
PL93301513A PL301513A1 (en) 1992-12-18 1993-12-16 Controllably released pharmaceutical composition containing nitroglycerin
CZ932775A CZ277593A3 (en) 1992-12-18 1993-12-16 Pharmaceutical preparation for peroral administration
JP5343465A JPH0748256A (ja) 1992-12-18 1993-12-16 ニセルゴリンを含有する制御放出性の製薬組成物
CN93112890A CN1093254A (zh) 1992-12-18 1993-12-17 含有麦角溴烟酯的控释药物组合物
HU9303633A HUT66371A (en) 1992-12-18 1993-12-17 Controlled-release pharmaceutical compositions containing nicergoline
KR1019930028487A KR950016748A (ko) 1992-12-18 1993-12-18 니세르골린을 함유하는 방출-조절성 약제학적 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922885A IT1256743B (it) 1992-12-18 1992-12-18 Composizioni farmaceutiche a rilascio controllato contenenti nicergolina

Publications (3)

Publication Number Publication Date
ITMI922885A0 true ITMI922885A0 (it) 1992-12-18
ITMI922885A1 ITMI922885A1 (it) 1994-06-18
IT1256743B IT1256743B (it) 1995-12-15

Family

ID=11364487

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922885A IT1256743B (it) 1992-12-18 1992-12-18 Composizioni farmaceutiche a rilascio controllato contenenti nicergolina

Country Status (8)

Country Link
EP (1) EP0602619A1 (it)
JP (1) JPH0748256A (it)
KR (1) KR950016748A (it)
CN (1) CN1093254A (it)
CZ (1) CZ277593A3 (it)
HU (1) HUT66371A (it)
IT (1) IT1256743B (it)
PL (1) PL301513A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786100B1 (fr) 1998-11-24 2002-03-01 Aventis Laboratoire Nouvelle application therapeutique de la nicergoline
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
JP3718398B2 (ja) * 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
CN102228450B (zh) * 2011-06-28 2012-10-31 重庆市庆余堂制药有限公司 尼麦角林胶囊及其生产方法
CN106333927A (zh) 2015-07-08 2017-01-18 昆山龙灯瑞迪制药有限公司 修饰释放的尼麦角林组合物
CN111904938A (zh) * 2020-05-15 2020-11-10 山东方明药业集团股份有限公司 一种尼麦角林片剂的制备方法
CN113081993A (zh) * 2021-04-15 2021-07-09 海南通用三洋药业有限公司 一种尼麦角林片剂的制备方法
CN113398089A (zh) * 2021-06-29 2021-09-17 海南通用三洋药业有限公司 一种尼麦角林胶囊的制备方法和尼麦角林胶囊

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015480A (en) * 1987-11-25 1991-05-14 Eli Lilly And Company Film coating formulations

Also Published As

Publication number Publication date
ITMI922885A1 (it) 1994-06-18
JPH0748256A (ja) 1995-02-21
CN1093254A (zh) 1994-10-12
CZ277593A3 (en) 1994-07-13
PL301513A1 (en) 1994-06-27
HU9303633D0 (en) 1994-04-28
HUT66371A (en) 1994-11-28
KR950016748A (ko) 1995-07-20
IT1256743B (it) 1995-12-15
EP0602619A1 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
GB2262445B (en) Controlled release pharmaceutical compositions
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DK0585252T3 (da) Farmaceutiske formuleringer
GB9016885D0 (en) Sustained release pharmaceutical compositions
FI930882A (fi) Farmaceutiska foereningar
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DE4294862T1 (de) Pharmazeutische Komposition
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
GB9103302D0 (en) Pharmaceutical formulations
ITMI922885A1 (it) Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DK136492D0 (da) A pharmaceutical formulation
ITMI922581A1 (it) Composizione farmaceutica
ITMI922580A1 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition
GB9221244D0 (en) Pharmaceutical formulations
GB9217602D0 (en) Pharmaceutical formulations
GB9207989D0 (en) Pharmaceutical formulations
GB9204774D0 (en) Pharmaceutical formulations
GB9207338D0 (en) Pharmaceutical formulations
GB9203212D0 (en) Pharmaceutical formulations
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
GB9103444D0 (en) Pharmaceutical formulations
GB9124803D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961223